Opera phenix maintenance agreement for multiple units

Ended Purchase Order Awarded Last action

Contract number
75N95022P00132
Awardee
Awarding agency
Obligated
$350,842

Award facts

Opportunity
Contract value 100% obligated
$350,841.84 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rockville, MD 20850, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $350,842

About this award

This firm fixed price purchase order for $350,841.84 was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, to provide maintenance agreements covering multiple units of high throughput microplate-based automated imaging systems. Specifically, the contract calls for gold service plans with preventative maintenance visits for seven Opera Phenix configurations, two Operetta CLS systems, one plate handler, and one Opera Phenix Plus system. These imaging systems will support ongoing stem cell growth and differentiation research as well as phenotypic screening conducted by the National Center for Advancing Translational Sciences. The period of performance is from February 22, 2022 through February 21, 2023 at the National Institutes of Health facilities located in Potomac, Maryland. There was no set-aside designation for this non-competitive award made under a combined synopsis/solicitation.

Quick answers

Who was awarded contract 75N95022P00132?

75N95022P00132 was awarded to Revvity Health Sciences, Inc. by National Institute on Drug Abuse (National Institutes of Health) on February 22, 2022.

How much is contract 75N95022P00132 worth?

The government has obligated $350,842 on 75N95022P00132.

Which agency awarded contract 75N95022P00132?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00132, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95022P00132 competed?

The extent of competition for 75N95022P00132 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award